Novo Holdings

Novo Holdings

Novo Holdings

$95,000,000 Venture capital (Series C)
Pulse 2.0

Biopharmaceutical Company Edgewise Therapeutics Closes $95 Million In Series C

$200,000,000 Venture capital (Series G)
neurons.AI

Precision medicine company Tempus lands $200M to expand into infectious diseases, mental health

Bioenergy International

IndianOil and LanzaTech poised to scale-up CO2 to food, feed and fuel

neurons.AI

Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance …

neurons.AI

Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance …

neurons.AI

Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance …

$64,000,000 Undisclosed
FinSMEs

Galecto Raises US$64M in Funding

TechCrunch

LanzaTech eyes two more spinoff companies

TechCrunch

LanzaTech is developing a small-scale waste biomass gasifier for ethanol production in India

$44,000,000 Venture capital (Series C)
FinSMEs

ReViral Raises $44M in Series C Financing

$11,400,000 Venture capital (Series A)
FinSMEs

Kebotix Raises Investment from ArcTern Ventures

$60,800,000 Venture capital
FinSMEs , Xconomy

F2G Secures US $60.8M in Financing

$93,500,000 Venture capital (Series C)
FinSMEs , Xconomy

Bolt Biotherapeutics Raises $93.5M in Series C Financing

CNBC Tech

Tempus: Health start-up backed by Groupon co-founder joins the fight against Covid-19

$85,000,000 Venture capital (Series C)
FinSMEs , Pulse 2.0

Checkmate Pharmaceuticals Raises $85M in Series C Financing

$11,500,000 Venture capital (Series A)
VentureBeat

Kebotix raises $11.5 million to automate lab experiments with AI and robotics

$100,000,000 Venture capital (Series G)
Pulse 2.0

Tempus: $100 Million Funding And $5 Billion Valuation

$88,000,000 Venture capital (Series B)
FinSMEs , Xconomy

Spruce Biosciences Raises $88M in Series B Financing

€11,000,000 Venture capital (Series B)
FinSMEs

HepaRegeniX Closes Over €11M Series B Financing round

PE HUB

VC-backed ReViral taps Musso as CFO